Mask-off outbursts by Maga insiders and most strikingly, the destruction and reconstruction of the presidential seat, with a huge new $300m ballroom, means Trump isn’t planning to leave the White House when his term ends, writes LINDA PENTZ GUNTER
Latest editorial
Patents: how the profit machine costs lives
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
LINING THEIR POCKETS: Gilead Sciences HQ in Foster City, California; (insert) Descovy used for HIV prevention through pre-exposure prophylaxis
[(L to R) Coolcaesar/CC - EEJCC/CC]
BEN CHACKO speaks with Knesset member OFER CASSIF about rising political violence, the prospects for peace and his continuous ‘silencing by suspension’
The City is leaning on Rachel Reeves to cut welfare spending — when what’s needed is cuts to all the benefits given to the mega rich, corporations and banks to help them not pay or blatantly dodge their fair share of tax, explains BERNIE EVANS
The choice between two Blairites to revamp the tepid centrism of our ruling party doesn’t even come as cold comfort as we wander the city streets suffering from their third decade of austerity and the fifth of wage stagnation, writes MATT KERR
ANN HENDERSON looks at the trailblazers of the Women’s Trade Union League and their successful fight for female factory inspectors — a battle that echoes in today’s workplace campaigns
HENRY FOWLER puts the strike of public-sector workers in New Zealand in the wider context of deteriorating employment conditions throughout the world’s major economies
MAT COWARD looks back at a protest 105 years ago this month, whose reporting by the media bears uncomfortable similarities with demos today
DECIDING a particular year when a scientific discovery or advance took place is often an arbitrary decision. Archimedes is said to have leapt from his bathtub and shouted “Eureka!” when he realised that the volume of any object, no matter how complicated, could be found by placing the object in water and measuring the volume of water it displaces.
But even that eureka moment is of dubious authenticity. It is rare for scientific research to advance in a glorious instant of revelation.
So when the journal Science named the HIV/AIDS drug lenacapavir as its “breakthrough of the year,” it shouldn’t be surprising that its story began far earlier.
Similar stories
Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS
A maverick’s self-inflicted snake bites could unlock breakthrough treatments – but they also reveal deeper tensions between noble scientific curiosity and cold corporate callousness, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
Science has always been mixed up with money and power, but as a decorative facade for megayachts, it risks leaving reality behind altogether, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
